INVA Innoviva Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INVA

Price (delayed)

$13.36

Market cap

$1.35B

P/E Ratio

5.34

Dividend/share

N/A

EPS

$2.5

Enterprise value

$1.46B

Highlights
The equity has surged by 67% year-on-year and by 18% since the previous quarter
The stock's price to earnings (P/E) is 48% less than its 5-year quarterly average of 10.2
Innoviva's quick ratio has soared by 75% from the previous quarter but it has decreased by 41% YoY
The debt has grown by 2.3% YoY
Sector: Healthcare
Industry: Biotechnology
Website: https://www.inva.com/
Peers: ONTX OPK

Key stats

What are the main financial stats of INVA
Market
Shares outstanding
101.41M
Market cap
$1.35B
Enterprise value
$1.46B
Valuations
Price to earnings (P/E)
5.34
Price to book (P/B)
2.14
Price to sales (P/S)
3.94
EV/EBIT
4.35
EV/EBITDA
4.17
EV/Sales
4.25
Earnings
Revenue
$343.63M
EBIT
$335.83M
EBITDA
$349.67M
Free cash flow
$323.74M
Per share
EPS
$2.5
Free cash flow per share
$3.19
Book value per share
$6.26
Revenue per share
$3.39
TBVPS
$10.74
Balance sheet
Total assets
$1.09B
Total liabilities
$391.61M
Debt
$387.73M
Equity
$634.46M
Working capital
$369.13M
Liquidity
Debt to equity
0.61
Current ratio
98.04
Quick ratio
97.76
Net debt/EBITDA
0.3
Margins
EBITDA margin
101.8%
Gross margin
100%
Net margin
73.7%
Operating margin
94.4%
Efficiency
Return on assets
26%
Return on equity
47.8%
Return on invested capital
33.7%
Return on capital employed
31%
Return on sales
97.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INVA stock price

How has the Innoviva stock price performed over time
Intraday
-0.37%
1 week
2.3%
1 month
0.83%
1 year
-1.55%
YTD
7.83%
QTD
-0.37%

Financial performance

How have Innoviva's revenue and profit performed over time
Revenue
$343.63M
Gross profit
$343.63M
Operating income
$324.49M
Net income
$253.09M
Gross margin
100%
Net margin
73.7%
INVA's net income is up by 34% year-on-year and by 13% since the previous quarter
The revenue has grown by 21% YoY and by 2% from the previous quarter
The gross profit is up by 21% YoY and by 2% from the previous quarter
INVA's operating income is up by 20% YoY

Growth

What is Innoviva's growth rate over time

Valuation

What is Innoviva stock price valuation
P/E
5.34
P/B
2.14
P/S
3.94
EV/EBIT
4.35
EV/EBITDA
4.17
EV/Sales
4.25
The stock's price to earnings (P/E) is 48% less than its 5-year quarterly average of 10.2
The company's EPS rose by 34% YoY and by 13% QoQ
The equity has surged by 67% year-on-year and by 18% since the previous quarter
The P/B is 11% below the last 4 quarters average of 2.4
The P/S is 36% lower than the 5-year quarterly average of 6.2 but 3.7% higher than the last 4 quarters average of 3.8
The revenue has grown by 21% YoY and by 2% from the previous quarter

Efficiency

How efficient is Innoviva business performance
INVA's return on equity is down by 25% year-on-year
The return on invested capital is up by 12% year-on-year
The company's return on sales rose by 9% QoQ and by 8% YoY
INVA's ROA is up by 4% from the previous quarter but it is down by 2.6% YoY

Dividends

What is INVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INVA.

Financial health

How did Innoviva financials performed over time
The total assets is 178% greater than the total liabilities
Innoviva's quick ratio has soared by 75% from the previous quarter but it has decreased by 41% YoY
The company's current ratio has surged by 75% QoQ but it fell by 41% YoY
The debt is 39% less than the equity
The equity has surged by 67% year-on-year and by 18% since the previous quarter
The debt to equity has declined by 39% year-on-year and by 14% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.